| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |
| 01/06/2000 | WO2000000462A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 01/06/2000 | WO2000000220A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 01/06/2000 | WO2000000217A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000216A2 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | WO2000000215A1 Particulate delivery systems and methods of use |
| 01/06/2000 | WO2000000182A2 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
| 01/06/2000 | WO2000000156A2 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999056776A3 Adjuvant composition and methods for its use |
| 01/06/2000 | WO1999055364A3 Proteins that direct the secretion of virulence proteins and vaccines comprising them |
| 01/06/2000 | WO1999051185A3 Human galactosyl transferases |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1999000137A3 Induction of an activated myeloid dendritic cell phenotype |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2336382A1 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2335508A1 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | CA2335506A1 Mucosal targeting immunisation |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
| 01/06/2000 | CA2330546A1 Immune system molecules |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/06/2000 | CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 01/05/2000 | EP0968721A2 Use of a composition comprising a peptide for the inhibition of HIV |
| 01/05/2000 | EP0968299A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 01/05/2000 | EP0968295A1 Vectors having enhanced expression and methods of making and uses thereof |
| 01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968210A1 Method of making arylamino triazolopyridines |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967991A1 Infectious bursitis vaccine |
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0967973A2 Mediation of cytokines by melanin |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | EP0610445B1 Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier |
| 01/05/2000 | EP0539420B1 substituted thiazolyl and substituted pyridinyl derivatives |
| 01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 01/05/2000 | DE19818842C1 Cold remedy containing sugar alcohol mixture such as Isomalt, having immunostimulant and antimicrobial activity |
| 01/05/2000 | CN1240481A Infections clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 01/05/2000 | CN1240438A Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 01/05/2000 | CN1240349A Stable glassy state powder formulations |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/04/2000 | US6011146 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011060 Treating a disease mediated by activation of the tumor necrosis factor |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2026610C Chemically modified allergens and process for the preparation thereof |
| 12/30/1999 | DE19828450A1 Use of bisphosphonic acid compounds and autoantigens or allergens |
| 12/29/1999 | WO1999067417A2 Fitness assay and associated methods |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
| 12/29/1999 | WO1999067254A2 Multi-drug resistant retroviral protease inhibitors and use thereof |
| 12/29/1999 | WO1999067243A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066955A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066947A1 Adjuvant therapy |
| 12/29/1999 | WO1999066941A1 Herbal extract composition and method with immune-boosting capability |
| 12/29/1999 | WO1999066879A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |
| 12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
| 12/29/1999 | WO1999055715A3 Polysaccharide-antigen conjugates |
| 12/29/1999 | WO1999055377A3 Polyol-ifn-beta conjugates |
| 12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966523A1 Method for the production of selected lymphocytes |
| 12/29/1999 | EP0966465A1 Inhibitors of impdh enzyme |
| 12/29/1999 | EP0966447A1 Small molecules useful in the treatment of inflammatory disease |
| 12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 12/29/1999 | EP0966437A1 5-aroylnaphthalene derivatives |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds |
| 12/29/1999 | EP0966301A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression |
| 12/29/1999 | EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | EP0556292B1 Hepatitis c virus asialoglycoproteins |
| 12/29/1999 | EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES |
| 12/29/1999 | CN1240001A Mutants of streptococcal toxin C and methods of use |
| 12/29/1999 | CN1239961A Pharmaceutically active tricyclic amines |
| 12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 12/29/1999 | CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs. |
| 12/29/1999 | CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them |